8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Apr 23, 2026·SEC
Material company update
Feb 5, 2026·SEC
IQVIA Holdings Inc.(IQV)Earnings, Financials & Key Ratios
IQV•NYSE
$176.47
$29.95B mkt cap·22.5× P/E·Price updated May 6, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryContract Research and Preclinical Services
AboutIQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.Show more
- Revenue$16.31B+5.9%
- EBITDA$3.43B+3.5%
- Net Income$1.36B-0.9%
- EPS (Diluted)7.84+4.7%
- Gross Margin26.28%-24.7%
- EBITDA Margin21.04%-2.3%
- Operating Margin14.02%-1.9%
- Net Margin8.34%-6.4%
- ROE21.42%-5.0%
- ROIC8.72%-1.9%
- Debt/Equity2.44+4.6%
- Interest Coverage3.18-8.8%
IQV Key Insights
IQVIA Holdings Inc. (IQV) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 22.3%
- ✓Strong 5Y profit CAGR of 37.3%
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 5.4% through buybacks
✗Weaknesses
- ✗High debt to equity ratio of 2.4x
- ✗Weak momentum: RS Rating 20 (bottom 20%)
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
IQV Price & Volume
IQVIA Holdings Inc. (IQV) stock price & volume — 10-year historical chart
Loading chart...
IQV Growth Metrics
IQVIA Holdings Inc. (IQV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years11.01%
5 Years7.5%
3 Years4.21%
TTM7.32%
Profit CAGR
10 Years13.39%
5 Years37.27%
3 Years7.62%
TTM3.82%
EPS CAGR
10 Years9.79%
5 Years40.54%
3 Years11.08%
TTM9.95%
Return on Capital
10 Years6.96%
5 Years9.62%
3 Years10.63%
Last Year11.01%
IQV Recent Earnings
IQVIA Holdings Inc. (IQV) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
May 5, 2026EPS
$2.90
Est $2.83
+2.5%
Revenue
$4.2B
Est $4.1B
+1.2%
Q1 2026
Feb 5, 2026EPS
$3.42
Est $3.40
+0.6%
Revenue
$4.4B
Est $4.2B
+2.9%
Q4 2025
Oct 28, 2025EPS
$3.00
Est $2.98
+0.7%
Revenue
$4.1B
Est $4.1B
+0.5%
Q3 2025
Jul 22, 2025EPS
$2.81
Est $2.77
+1.4%
Revenue
$4.0B
Est $4.0B
+1.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $2.90vs $2.83+2.5% | $4.2Bvs $4.1B+1.2% |
| Q1 2026 | Feb 5, 2026 | $3.42vs $3.40+0.6% | $4.4Bvs $4.2B+2.9% |
| Q4 2025 | Oct 28, 2025 | $3.00vs $2.98+0.7% | $4.1Bvs $4.1B+0.5% |
| Q3 2025 | Jul 22, 2025 | $2.81vs $2.77+1.4% | $4.0Bvs $4.0B+1.2% |
Based on last 12 quarters of dataView full earnings history →
IQV Peer Comparison
IQVIA Holdings Inc. (IQV) competitors in Contract Research and Preclinical Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CRL | 8.97B | 181.73 | -62.45 | -0.85% | -3.59% | -4.34% | 0.95 | |
 ICLR | 9.48B | 124.13 | 13.03 | 1.99% | 7.4% | 6.32% | 0.38 | |
 PRA | 1.27B | 24.60 | 24.85 | -2.67% | 6.04% | 4.95% | 0.32 | |
 MEDP | 12.19B | 426.79 | 27.93 | 19.97% | 17.19% | 120.89% | 0.55 | |
 VEEV | 27.2B | 167.29 | 30.75 | 16.34% | 28.44% | 13.41% | 0.01 | |
 INCY | 19.95B | 99.85 | 15.58 | 21.22% | 26.71% | 29.31% | 0.01 | |
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 HCAT | 111.47M | 1.57 | -0.62 | 1.48% | -57.2% | -54.67% | 0.08 |
Compare IQV vs Peers
IQVIA Holdings Inc. (IQV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
IQV Income Statement
IQVIA Holdings Inc. (IQV) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 9.7B | 10.41B | 11.09B | 11.36B | 13.87B | 14.41B | 14.98B | 15.4B | 16.31B | 16.63B |
| Revenue Growth % | 42.36% | 7.32% | 6.49% | 2.44% | 22.14% | 3.86% | 3.98% | 2.81% | 5.87% | 7.32% |
| Cost of Goods Sold | 6.3B | 6.75B | 7.3B | 7.5B | 9.23B | 9.38B | 9.74B | 10.03B | 12.02B | 12.29B |
| COGS % of Revenue | 64.95% | 64.79% | 65.84% | 66.03% | 66.55% | 65.11% | 65.04% | 65.11% | 73.72% | - |
| Gross Profit | 3.4B▲ 0% | 3.67B▲ 7.8% | 3.79B▲ 3.3% | 3.86B▲ 1.9% | 4.64B▲ 20.3% | 5.03B▲ 8.3% | 5.24B▲ 4.2% | 5.38B▲ 2.6% | 4.29B▼ 20.3% | 4.34B▲ 0% |
| Gross Margin % | 35.05% | 35.21% | 34.16% | 33.97% | 33.45% | 34.89% | 34.96% | 34.89% | 26.28% | 26.11% |
| Gross Profit Growth % | 64.54% | 7.79% | 3.33% | 1.87% | 20.26% | 8.34% | 4.2% | 2.6% | -20.26% | - |
| Operating Expenses | 2.74B | 2.92B | 3.01B | 3.13B | 3.25B | 3.23B | 3.26B | 3.17B | 2B | 2.04B |
| OpEx % of Revenue | 28.2% | 28.09% | 27.16% | 27.54% | 23.41% | 22.41% | 21.77% | 20.6% | 12.26% | - |
| Selling, General & Admin | 1.6B | 1.72B | 1.73B | 1.79B | 1.96B | 2.07B | 2.05B | 1.99B | 2B | 1.99B |
| SG&A % of Revenue | 16.54% | 16.48% | 15.64% | 15.75% | 14.16% | 14.37% | 13.7% | 12.93% | 12.26% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 1.11B | 1.21B | 1.28B | 1.34B | 1.28B | 1.16B | 1.21B | 1.18B | 0 | 2M |
| Operating Income | 719M▲ 0% | 741M▲ 3.1% | 777M▲ 4.9% | 731M▼ 5.9% | 1.39B▲ 90.6% | 1.8B▲ 29.1% | 1.98B▲ 9.9% | 2.2B▲ 11.4% | 2.29B▲ 3.9% | 2.31B▲ 0% |
| Operating Margin % | 7.41% | 7.12% | 7.01% | 6.44% | 10.04% | 12.48% | 13.19% | 14.29% | 14.02% | 13.86% |
| Operating Income Growth % | 11.99% | 3.06% | 4.86% | -5.92% | 90.56% | 29.15% | 9.89% | 11.38% | 3.86% | - |
| EBITDA | 1.73B | 1.88B | 1.98B | 2.02B | 2.66B | 2.93B | 3.1B | 3.32B | 3.43B | 3.47B |
| EBITDA Margin % | 17.83% | 18.08% | 17.85% | 17.77% | 19.15% | 20.33% | 20.7% | 21.53% | 21.04% | 20.88% |
| EBITDA Growth % | 85.82% | 8.79% | 5.15% | 1.97% | 31.66% | 10.24% | 5.91% | 6.9% | 3.47% | 4.11% |
| D&A (Non-Cash Add-back) | 1.01B | 1.14B | 1.2B | 1.29B | 1.26B | 1.13B | 1.13B | 1.11B | 1.14B | 1.17B |
| EBIT | 640M | 742M | 799M | 789M | 1.5B | 1.78B | 2.13B | 2.34B | 2.32B | 2.35B |
| Net Interest Income | -339M | -406M | -438M | -410M | -369M | -403M | -636M | -623M | -684M | -716M |
| Interest Income | 7M | 8M | 9M | 6M | 6M | 13M | 36M | 47M | 45M | 40M |
| Interest Expense | 346M | 414M | 447M | 416M | 375M | 416M | 672M | 670M | 729M | 756M |
| Other Income/Expense | -361M | -398M | -434M | -351M | -259M | -448M | -518M | -533M | -674M | -674M |
| Pretax Income | 304M▲ 0% | 343M▲ 12.8% | 343M▲ 0.0% | 380M▲ 10.8% | 1.13B▲ 198.4% | 1.35B▲ 19.1% | 1.46B▲ 8.0% | 1.67B▲ 14.4% | 1.61B▼ 3.4% | 1.63B▲ 0% |
| Pretax Margin % | 3.13% | 3.29% | 3.09% | 3.35% | 8.17% | 9.38% | 9.74% | 10.83% | 9.89% | 9.81% |
| Income Tax | -987M | 59M | 116M | 72M | 163M | 260M | 101M | 296M | 252M | 250M |
| Effective Tax Rate % | -324.67% | 17.2% | 33.82% | 18.95% | 14.37% | 19.25% | 6.92% | 17.74% | 15.62% | 15.33% |
| Net Income | 1.31B▲ 0% | 259M▼ 80.2% | 191M▼ 26.3% | 279M▲ 46.1% | 966M▲ 246.2% | 1.09B▲ 12.9% | 1.36B▲ 24.5% | 1.37B▲ 1.1% | 1.36B▼ 0.9% | 1.39B▲ 0% |
| Net Margin % | 13.49% | 2.49% | 1.72% | 2.46% | 6.96% | 7.57% | 9.06% | 8.91% | 8.34% | 8.33% |
| Net Income Growth % | 1038.26% | -80.21% | -26.25% | 46.07% | 246.24% | 12.94% | 24.47% | 1.1% | -0.95% | 3.82% |
| Net Income (Continuing) | 1.3B | 284M | 227M | 308M | 971M | 1.09B | 1.36B | 1.37B | 1.36B | 1.38B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 249M | 240M | 260M | 279M | 0 | 0 | 0 | 0 | 127M | 128M |
| EPS (Diluted) | 5.88▲ 0% | 1.24▼ 78.9% | 0.96▼ 22.6% | 1.43▲ 49.0% | 4.95▲ 246.2% | 5.72▲ 15.6% | 7.29▲ 27.4% | 7.49▲ 2.7% | 7.84▲ 4.7% | 8.16▲ 0% |
| EPS Growth % | 673.68% | -78.91% | -22.58% | 48.96% | 246.15% | 15.56% | 27.45% | 2.74% | 4.67% | 9.95% |
| EPS (Basic) | 6.01 | 1.27 | 0.98 | 1.46 | 5.05 | 5.82 | 7.39 | 7.57 | 7.91 | - |
| Diluted Shares Outstanding | 222.6M | 208.2M | 199.6M | 195M | 195M | 190.6M | 186.3M | 183.4M | 173.5M | 169.8M |
| Basic Shares Outstanding | 217.8M | 203.7M | 195.1M | 191.3M | 191.4M | 187.6M | 183.8M | 181.3M | 171.9M | 168.4M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
IQV Balance Sheet
IQVIA Holdings Inc. (IQV) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 3.55B | 3.87B | 4.13B | 5.09B | 4.76B | 4.98B | 5.6B | 5.83B | 6.25B | 6.22B |
| Cash & Short-Term Investments | 1B | 938M | 899M | 1.9B | 1.48B | 1.31B | 1.5B | 1.84B | 2.14B | 1.95B |
| Cash Only | 959M | 891M | 837M | 1.81B | 1.37B | 1.22B | 1.38B | 1.7B | 1.98B | 1.95B |
| Short-Term Investments | 46M | 47M | 62M | 88M | 111M | 93M | 120M | 141M | 161M | 0 |
| Accounts Receivable | 2.14B | 2.46B | 2.64B | 2.47B | 2.61B | 2.96B | 3.41B | 3.24B | 3.43B | 3.92B |
| Days Sales Outstanding | 80.66 | 86.34 | 86.84 | 79.24 | 68.64 | 74.98 | 83.14 | 76.77 | 76.69 | 77.18 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 259M | 322M | 451M | 563M | 521M | 561M | 546M | 592M | 519M | 352M |
| Total Non-Current Assets | 19.29B | 18.68B | 19.13B | 19.47B | 19.93B | 20.36B | 21.09B | 21.07B | 23.7B | 23.45B |
| Property, Plant & Equipment | 440M | 434M | 954M | 953M | 903M | 863M | 819M | 773M | 823M | 809M |
| Fixed Asset Turnover | 22.05x | 23.99x | 11.62x | 11.92x | 15.36x | 16.70x | 18.30x | 19.93x | 19.82x | 20.33x |
| Goodwill | 11.85B | 11.8B | 12.16B | 12.65B | 13.3B | 13.92B | 14.57B | 14.71B | 16.62B | 16.54B |
| Intangible Assets | 6.59B | 5.95B | 5.51B | 5.21B | 4.94B | 4.82B | 4.84B | 4.5B | 4.96B | 4.8B |
| Long-Term Investments | 78M | 142M | 152M | 162M | 164M | 162M | 239M | 374M | 432M | 1.34B |
| Other Non-Current Assets | 235M | 239M | 227M | 386M | 491M | 472M | 455M | 520M | 505M | 2.34B |
| Total Assets | 22.74B▲ 0% | 22.55B▼ 0.8% | 23.25B▲ 3.1% | 24.56B▲ 5.6% | 24.69B▲ 0.5% | 25.34B▲ 2.6% | 26.68B▲ 5.3% | 26.9B▲ 0.8% | 29.94B▲ 11.3% | 29.68B▲ 0% |
| Asset Turnover | 0.43x | 0.46x | 0.48x | 0.46x | 0.56x | 0.57x | 0.56x | 0.57x | 0.54x | 0.57x |
| Asset Growth % | 7.23% | -0.85% | 3.11% | 5.65% | 0.51% | 2.62% | 5.3% | 0.82% | 11.32% | 34.09% |
| Total Current Liabilities | 2.9B | 3.53B | 3.94B | 4.56B | 5.24B | 5.58B | 6.49B | 6.96B | 8.34B | 8.33B |
| Accounts Payable | 322M | 437M | 2.51B | 581M | 621M | 645M | 709M | 736M | 3.75B | 3.64B |
| Days Payables Outstanding | 18.65 | 23.64 | 125.6 | 28.28 | 24.55 | 25.09 | 26.56 | 26.78 | 113.87 | 106.47 |
| Short-Term Debt | 103M | 100M | 100M | 149M | 91M | 152M | 718M | 1.15B | 1.84B | 1.84B |
| Deferred Revenue (Current) | 733M | 1.01B | 1.01B | 1.25B | 1.82B | 1.8B | 1.8B | 1.78B | 2.12B | 4.38B |
| Other Current Liabilities | 666M | -1.17B | 211M | 1.09B | 1.15B | 1.13B | 1.26B | 1.1B | 489M | 413M |
| Current Ratio | 1.22x | 1.10x | 1.05x | 1.12x | 0.91x | 0.89x | 0.86x | 0.84x | 0.75x | 0.75x |
| Quick Ratio | 1.22x | 1.10x | 1.05x | 1.12x | 0.91x | 0.89x | 0.86x | 0.84x | 0.75x | 0.75x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | -29.29 |
| Total Non-Current Liabilities | 11.48B | 12.06B | 13.04B | 13.73B | 13.41B | 13.99B | 14.08B | 13.88B | 14.98B | 15B |
| Long-Term Debt | 10.12B | 10.91B | 11.54B | 12.38B | 12.03B | 12.6B | 12.96B | 12.84B | 14.11B | 232M |
| Capital Lease Obligations | 0 | 0 | 396M | 371M | 313M | 264M | 223M | 173M | 225M | 668M |
| Deferred Tax Liabilities | 918M | 736M | 646M | 338M | 410M | 464M | 202M | 196M | 179M | 761M |
| Other Non-Current Liabilities | 440M | 418M | 456M | 633M | 649M | 671M | 698M | 668M | 463M | 16.44B |
| Total Liabilities | 14.38B | 15.6B | 16.99B | 18.28B | 18.65B | 19.57B | 20.57B | 20.83B | 23.31B | 23.33B |
| Total Debt | 10.22B | 11.01B | 12.04B | 12.9B | 12.44B | 13.01B | 13.9B | 14.16B | 16.17B | 2.08B |
| Net Debt | 9.27B | 10.12B | 11.2B | 11.09B | 11.07B | 11.79B | 12.52B | 12.45B | 14.19B | 129M |
| Debt / Equity | 1.22x | 1.58x | 1.92x | 2.05x | 2.06x | 2.26x | 2.27x | 2.33x | 2.44x | 2.44x |
| Debt / EBITDA | 5.91x | 5.85x | 6.08x | 6.39x | 4.68x | 4.44x | 4.48x | 4.27x | 4.71x | 0.60x |
| Net Debt / EBITDA | 5.36x | 5.38x | 5.66x | 5.50x | 4.17x | 4.03x | 4.04x | 3.76x | 4.14x | 4.14x |
| Interest Coverage | 1.85x | 1.79x | 1.79x | 1.90x | 4.01x | 4.28x | 3.17x | 3.49x | 3.18x | 3.10x |
| Total Equity | 8.36B▲ 0% | 6.95B▼ 16.8% | 6.26B▼ 9.9% | 6.28B▲ 0.3% | 6.04B▼ 3.8% | 5.76B▼ 4.6% | 6.11B▲ 6.0% | 6.07B▼ 0.7% | 6.63B▲ 9.3% | 6.35B▲ 0% |
| Equity Growth % | -5.67% | -16.8% | -9.94% | 0.27% | -3.79% | -4.58% | 6.02% | -0.74% | 9.28% | -8.21% |
| Book Value per Share | 37.55 | 33.40 | 31.38 | 32.21 | 30.98 | 30.25 | 32.81 | 33.08 | 38.21 | 37.39 |
| Total Shareholders' Equity | 8.11B | 6.71B | 6B | 6B | 6.04B | 5.76B | 6.11B | 6.07B | 6.5B | 6.22B |
| Common Stock | 10.78B | 10.9B | 11.05B | 3M | 3M | 10.9B | 3M | 3M | 11.38B | 11.4B |
| Retained Earnings | 655M | 807M | 998M | 1.28B | 2.24B | 3.33B | 4.69B | 6.07B | 7.42B | 7.7B |
| Treasury Stock | -3.37B | -4.77B | -5.73B | -6.17B | -6.57B | -7.74B | -8.74B | -10.1B | -11.36B | -11.91B |
| Accumulated OCI | 46M | -224M | -311M | -205M | -406M | -727M | -867M | -1.04B | -943M | -968M |
| Minority Interest | 249M | 240M | 260M | 279M | 0 | 0 | 0 | 0 | 127M | 128M |
IQV Cash Flow Statement
IQVIA Holdings Inc. (IQV) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 970M | 1.25B | 1.42B | 1.96B | 2.94B | 2.26B | 2.15B | 2.72B | 2.65B | 2.65B |
| Operating CF Margin % | 10% | 12.04% | 12.78% | 17.25% | 21.21% | 15.68% | 14.34% | 17.63% | 16.27% | - |
| Operating CF Growth % | 12.79% | 29.28% | 13% | 38.25% | 50.18% | -23.18% | -4.91% | 26.38% | -2.28% | -6.87% |
| Net Income | 1.33B | 284M | 227M | 308M | 966M | 1.09B | 1.36B | 1.37B | 1.36B | 1.39B |
| Depreciation & Amortization | 1.01B | 1.14B | 1.2B | 1.29B | 1.26B | 1.13B | 1.13B | 1.11B | 1.14B | 1.17B |
| Stock-Based Compensation | 106M | 113M | 146M | 95M | 170M | 194M | 217M | 206M | 247M | 180M |
| Deferred Taxes | -1.22B | -177M | -157M | -176M | -138M | -115M | -269M | -129M | -180M | -177M |
| Other Non-Cash Items | 33M | -1M | -20M | -14M | 0 | 44M | -2M | -6M | -43M | -166M |
| Working Capital Changes | -292M | -106M | 19M | 459M | 680M | -84M | -280M | 158M | 125M | 313M |
| Change in Receivables | -142M | -297M | -124M | 255M | -138M | -421M | -388M | 182M | 60M | 125M |
| Change in Inventory | -136M | -184M | -116M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 90M | 368M | 240M | 253M | 244M | 427M | 267M | 115M | -96M | 0 |
| Cash from Investing | -1.19B | -810M | -1.19B | -796M | -2.1B | -2.01B | -1.6B | -1.44B | -2.31B | -2.2B |
| Capital Expenditures | -369M | -459M | -582M | -616M | -640M | -674M | -649M | -602M | 0 | -32M |
| CapEx % of Revenue | 3.8% | 4.41% | 5.25% | 5.42% | 4.61% | 4.68% | 4.33% | 3.91% | 3.7% | - |
| Acquisitions | -827M | -326M | -588M | -167M | -1.46B | -1.33B | -876M | -710M | -1.71B | -1.6B |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 2M | -457M | 27M | -2M | 0 | 8M | 5M | 2M | -573M | -540M |
| Cash from Financing | -72M | -452M | -276M | -217M | -1.24B | -329M | -382M | -878M | -150M | -325M |
| Debt Issued (Net) | 2.51B | 1.01B | 747M | 342M | 70M | 941M | 802M | 553M | 1.21B | 1.24B |
| Equity Issued (Net) | -2.62B | -1.41B | -949M | -447M | -406M | -1.17B | -992M | -1.35B | -1.31B | -456M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -2.62B | -1.41B | -949M | -447M | -406M | -1.17B | -992M | -1.35B | -1.24B | -389M |
| Other Financing | 37M | -62M | -74M | -112M | -899M | -102M | -192M | -81M | -44M | -1.11B |
| Net Change in Cash | -239M▲ 0% | -68M▲ 71.5% | -54M▲ 20.6% | 977M▲ 1909.3% | -448M▼ 145.9% | -150M▲ 66.5% | 160M▲ 206.7% | 326M▲ 103.8% | 278M▼ 14.7% | 207M▲ 0% |
| Free Cash Flow | 601M▲ 0% | 795M▲ 32.3% | 835M▲ 5.0% | 1.34B▲ 60.8% | 2.3B▲ 71.4% | 1.59B▼ 31.1% | 1.5B▼ 5.4% | 2.11B▲ 40.9% | 2.05B▼ 3.0% | 2.67B▲ 0% |
| FCF Margin % | 6.19% | 7.64% | 7.53% | 11.82% | 16.59% | 11.01% | 10.01% | 13.72% | 12.58% | 16.07% |
| FCF Growth % | -13.65% | 32.28% | 5.03% | 60.84% | 71.41% | -31.1% | -5.42% | 40.93% | -2.98% | 23.53% |
| FCF per Share | 2.70 | 3.82 | 4.18 | 6.89 | 11.81 | 8.32 | 8.05 | 11.53 | 11.82 | 11.82 |
| FCF Conversion (FCF/Net Income) | 0.74x | 4.84x | 7.42x | 7.02x | 3.05x | 2.07x | 1.58x | 1.98x | 1.95x | 1.93x |
| Interest Paid | 320M | 398M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 195M | 211M | 0 | 0 | 222M | 255M | 340M | 295M | 0 | 0 |
IQV Key Ratios
IQVIA Holdings Inc. (IQV) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 15.2% | 3.38% | 2.89% | 4.45% | 15.68% | 18.48% | 22.87% | 22.55% | 21.42% | 22.11% |
| Return on Invested Capital (ROIC) | 3.32% | 3.2% | 3.37% | 3.15% | 6.06% | 7.78% | 8.19% | 8.89% | 8.72% | 8.72% |
| Gross Margin | 35.05% | 35.21% | 34.16% | 33.97% | 33.45% | 34.89% | 34.96% | 34.89% | 26.28% | 26.11% |
| Net Margin | 13.49% | 2.49% | 1.72% | 2.46% | 6.96% | 7.57% | 9.06% | 8.91% | 8.34% | 8.33% |
| Debt / Equity | 1.22x | 1.58x | 1.92x | 2.05x | 2.06x | 2.26x | 2.27x | 2.33x | 2.44x | 2.44x |
| Interest Coverage | 1.85x | 1.79x | 1.79x | 1.90x | 4.01x | 4.28x | 3.17x | 3.49x | 3.18x | 3.10x |
| FCF Conversion | 0.74x | 4.84x | 7.42x | 7.02x | 3.05x | 2.07x | 1.58x | 1.98x | 1.95x | 1.93x |
| Revenue Growth | 42.36% | 7.32% | 6.49% | 2.44% | 22.14% | 3.86% | 3.98% | 2.81% | 5.87% | 7.32% |
IQV SEC Filings & Documents
IQVIA Holdings Inc. (IQV) SEC filings — annual & quarterly reports (10-K, 10-Q)
IQV Frequently Asked Questions
IQVIA Holdings Inc. (IQV) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
IQVIA Holdings Inc. (IQV) reported $16.63B in revenue for fiscal year 2025. This represents a 284% increase from $4.33B in 2011.
IQVIA Holdings Inc. (IQV) grew revenue by 5.9% over the past year. This is steady growth.
Yes, IQVIA Holdings Inc. (IQV) is profitable, generating $1.39B in net income for fiscal year 2025 (8.3% net margin).
Dividend & Returns
IQVIA Holdings Inc. (IQV) has a return on equity (ROE) of 21.4%. This is excellent, indicating efficient use of shareholder capital.
IQVIA Holdings Inc. (IQV) generated $2.67B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More IQV
IQVIA Holdings Inc. (IQV) financial analysis — history, returns, DCA and operating performance tools
Full IQV Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates